Pharmanutra
Develops and distributes nutritional supplements and medical devices based on research.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
Description
PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-26 10:28 |
Relazione illustrativa azioni proprie
|
Italian | 424.3 KB | ||
| 2024-03-26 10:27 |
Report on the remuneration policy and the remuneration paid
|
English | 710.1 KB | ||
| 2024-03-26 10:26 |
Relazione sulla Politica di remunerazione e sui compensi corrisposti
|
Italian | 717.4 KB | ||
| 2024-03-26 10:25 |
Avviso di deposito documentazione / Notice of publication of documents
|
Italian | 147.7 KB | ||
| 2024-03-25 17:32 |
ANNUAL FINANCIAL STATEMENTS 2023
|
English | 4.7 MB | ||
| 2024-03-25 17:31 |
Relazione finanziaria annuale 2023
|
Italian | 10.6 MB | ||
| 2024-03-25 17:28 |
REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE OF PHARMANUTRA S.P.A. - …
|
English | 1.3 MB | ||
| 2024-03-25 17:27 |
RELAZIONE SUL GOVERNO SOCIETARIO E GLI ASSETTI PROPRIETARI DI PHARMANUTRA S.p.A…
|
Italian | 1.5 MB | ||
| 2024-03-25 17:26 |
PHN: Avviso di deposito documentazione/Notice of publication of documents
|
Italian | 149.2 KB | ||
| 2024-03-18 17:58 |
COMPANY PRESENTATION_EURONEXT STAR CONFERENCE 2024
|
English | 4.1 MB | ||
| 2024-03-15 18:26 |
Proxy form ex 135 undecies
|
English | 319.6 KB | ||
| 2024-03-15 18:25 |
Proxy form ex 135 novies
|
English | 282.6 KB | ||
| 2024-03-15 18:24 |
Modulo di delega ex 135 undecies
|
Italian | 342.5 KB | ||
| 2024-03-15 18:23 |
Modulo di delega ex 135 novies
|
Italian | 306.3 KB | ||
| 2024-03-15 18:15 |
Explanatory memorandum on the increase in compensation for the Board of Statuto…
|
English | 362.9 KB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
